(2-129) Evaluation of an Argatroban Protocol for Confirmed/Suspected Heparin Induced Thrombocytopenia (HIT)

Monday, December 5, 2022

10:45 AM – 11:45 AM

Location: Bayside A, Level 1

Category: Evaluative Study
Topic: Drug Information/Drug Use Evaluation

Co-Author(s): Andy Kim

Primary Author(s)

Markus Melbardis
Student
University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Colorado